Literature DB >> 19075564

CDC25A: a rebel within the CDC25 phosphatases family?

Anne Fernandez-Vidal1, Anne Mazars, Stéphane Manenti.   

Abstract

CDC25 dual specificity phosphatases activate the cyclin-dependent kinase complexes, allowing timely ordered progression through out the different phases of the eukaryotic cell cycle. In humans, there are three genes coding for the CDC25A, B and C proteins with both different and redundant specificities and regulations. The CDC25A member of this family acts during the G1 phase and at the G1/S transition by activating the CDK2/cyclin E and CDK2/cyclin A complexes, a function apparently not shared by the other members. In consequence, CDC25A is submitted to extra-cellular signals-dependent regulations involving in particular mitogenic signal transducers, and leading to modifications of its stability, its localization or its activity. In addition, CDC25A is up-regulated in various cancers, and the molecular mechanisms leading to this up-regulation are far from being understood. In this review, we will synthesize the current knowledge about CDC25A molecular regulations, and try to integrate these data in the cell proliferation and apoptotic functions described for the protein.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19075564     DOI: 10.2174/187152008786847684

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  17 in total

1.  Part II-mechanism of adaptation: A549 cells adapt to high concentration of nitric oxide through bypass of cell cycle checkpoints.

Authors:  Madeeha Aqil; Zane Deliu; Kim M Elseth; Grace Shen; Jiaping Xue; James A Radosevich
Journal:  Tumour Biol       Date:  2013-11-17

2.  CyclinD-CDK4/6 complexes phosphorylate CDC25A and regulate its stability.

Authors:  C Dozier; L Mazzolini; C Cénac; C Froment; O Burlet-Schiltz; A Besson; S Manenti
Journal:  Oncogene       Date:  2017-02-13       Impact factor: 9.867

3.  CDC25A targeting by miR-483-3p decreases CCND-CDK4/6 assembly and contributes to cell cycle arrest.

Authors:  T Bertero; C Gastaldi; I Bourget-Ponzio; B Mari; G Meneguzzi; P Barbry; G Ponzio; R Rezzonico
Journal:  Cell Death Differ       Date:  2013-02-22       Impact factor: 15.828

4.  Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas.

Authors:  Henriett Butz; Kinga Németh; Dóra Czenke; István Likó; Sándor Czirják; Vladimir Zivkovic; Kornélia Baghy; Márta Korbonits; Ilona Kovalszky; Péter Igaz; Károly Rácz; Attila Patócs
Journal:  Pathol Oncol Res       Date:  2016-12-21       Impact factor: 3.201

5.  Inhibition of Cdc25A suppresses hepato-renal cystogenesis in rodent models of polycystic kidney and liver disease.

Authors:  Tatyana V Masyuk; Brynn N Radtke; Angela J Stroope; Jesús M Banales; Anatoliy I Masyuk; Sergio A Gradilone; Gabriella Bedekovicsne Gajdos; Natasha Chandok; Jason L Bakeberg; Christopher J Ward; Erik L Ritman; Hiroaki Kiyokawa; Nicholas F LaRusso
Journal:  Gastroenterology       Date:  2011-12-07       Impact factor: 22.682

6.  The NEDD8 Conjugation Pathway and Its Relevance in Cancer Biology and Therapy.

Authors:  Teresa A Soucy; Lawrence R Dick; Peter G Smith; Michael A Milhollen; James E Brownell
Journal:  Genes Cancer       Date:  2010-07

7.  MiR-322/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A.

Authors:  Sukumar Sarkar; Bijan K Dey; Anindya Dutta
Journal:  Mol Biol Cell       Date:  2010-05-12       Impact factor: 4.138

Review 8.  MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

Authors:  Seyed Esmaeil Ahmadi; Samira Rahimi; Bahman Zarandi; Rouzbeh Chegeni; Majid Safa
Journal:  J Hematol Oncol       Date:  2021-08-09       Impact factor: 17.388

9.  CDC25A(Q110del): a novel cell division cycle 25A isoform aberrantly expressed in non-small cell lung cancer.

Authors:  Rania H Younis; Wei Cao; Ruxian Lin; Ronghui Xia; Zhenqiu Liu; Martin J Edelman; Yuping Mei; Li Mao; Hening Ren
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240

10.  High levels of oncomiR-21 contribute to the senescence-induced growth arrest in normal human cells and its knock-down increases the replicative lifespan.

Authors:  Hanna Dellago; Barbara Preschitz-Kammerhofer; Lucia Terlecki-Zaniewicz; Carina Schreiner; Klaus Fortschegger; Martina W-F Chang; Matthias Hackl; Rossella Monteforte; Harald Kühnel; Markus Schosserer; Florian Gruber; Erwin Tschachler; Marcel Scheideler; Regina Grillari-Voglauer; Johannes Grillari; Matthias Wieser
Journal:  Aging Cell       Date:  2013-04-19       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.